Ahmad N - Search Results

1

Polo-like kinase 1 facilitates loss of Pten tumor suppressor-induced prostate cancer formation.

Liu XS, Song B, Elzey BD, Ratliff TL, Konieczny SF, Cheng L, Ahmad N, Liu X. Liu XS, et al. Among authors: ahmad n. J Biol Chem. 2011 Oct 14;286(41):35795-35800. doi: 10.1074/jbc.C111.269050. Epub 2011 Sep 2. J Biol Chem. 2011. PMID: 21890624 Free PMC article.

2

Involvement of Bcl-2 and Bax in photodynamic therapy-mediated apoptosis. Antisense Bcl-2 oligonucleotide sensitizes RIF 1 cells to photodynamic therapy apoptosis.

Srivastava M, Ahmad N, Gupta S, Mukhtar H. Srivastava M, et al. Among authors: ahmad n. J Biol Chem. 2001 May 4;276(18):15481-8. doi: 10.1074/jbc.M006920200. Epub 2001 Jan 31. J Biol Chem. 2001. PMID: 11278320 Free article.

3

Polo-like kinase (Plk) 1: a novel target for the treatment of prostate cancer.

Ahmad N. Ahmad N. FASEB J. 2004 Jan;18(1):5-7. doi: 10.1096/fj.03-0848hyp. FASEB J. 2004. PMID: 14718382

4

Modulation of phosphatidylinositol-3-kinase/protein kinase B- and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells.

Siddiqui IA, Adhami VM, Afaq F, Ahmad N, Mukhtar H. Siddiqui IA, et al. Among authors: ahmad n. J Cell Biochem. 2004 Feb 1;91(2):232-42. doi: 10.1002/jcb.10737. J Cell Biochem. 2004. PMID: 14743383

5

Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer.

Reagan-Shaw S, Ahmad N. Reagan-Shaw S, et al. Among authors: ahmad n. FASEB J. 2005 Apr;19(6):611-3. doi: 10.1096/fj.04-2910fje. Epub 2005 Jan 20. FASEB J. 2005. PMID: 15661849

6

Polo-like kinase (Plk) 1 as a target for prostate cancer management.

Reagan-Shaw S, Ahmad N. Reagan-Shaw S, et al. Among authors: ahmad n. IUBMB Life. 2005 Oct;57(10):677-82. doi: 10.1080/15216540500305910. IUBMB Life. 2005. PMID: 16223707 Free article. Review.

7

Role of sirtuin histone deacetylase SIRT1 in prostate cancer. A target for prostate cancer management via its inhibition?

Jung-Hynes B, Nihal M, Zhong W, Ahmad N. Jung-Hynes B, et al. Among authors: ahmad n. J Biol Chem. 2009 Feb 6;284(6):3823-32. doi: 10.1074/jbc.M807869200. Epub 2008 Dec 15. J Biol Chem. 2009. PMID: 19075016 Free PMC article.

8

Targeted depletion of Polo-like kinase (Plk) 1 through lentiviral shRNA or a small-molecule inhibitor causes mitotic catastrophe and induction of apoptosis in human melanoma cells.

Schmit TL, Zhong W, Setaluri V, Spiegelman VS, Ahmad N. Schmit TL, et al. Among authors: ahmad n. J Invest Dermatol. 2009 Dec;129(12):2843-53. doi: 10.1038/jid.2009.172. Epub 2009 Jun 25. J Invest Dermatol. 2009. PMID: 19554017 Free PMC article.

9

Polo-like kinase 1 (Plk1) in non-melanoma skin cancers.

Schmit TL, Zhong W, Nihal M, Ahmad N. Schmit TL, et al. Among authors: ahmad n. Cell Cycle. 2009 Sep 1;8(17):2697-702. doi: 10.4161/cc.8.17.9413. Epub 2009 Sep 2. Cell Cycle. 2009. PMID: 19652546 Free PMC article.

10

Modulating polo-like kinase 1 as a means for cancer chemoprevention.

Schmit TL, Ledesma MC, Ahmad N. Schmit TL, et al. Among authors: ahmad n. Pharm Res. 2010 Jun;27(6):989-98. doi: 10.1007/s11095-010-0051-8. Epub 2010 Jan 27. Pharm Res. 2010. PMID: 20107874 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,514 results

Search Page

Filters